Treatment Selection for Early to Intermediate Hepatocellular Carcinoma

被引：1

作者：

Nouso, Kazuhiro ^{[1
]}

Ohki, Takamasa ^{[2
]}

Yamashita, Tatsuya ^{[3
]}

Takaki, Haruyuki ^{[4
]}

Liu, Chien-Au ^{[5
]}

Kang, Tae Wook ^{[6
]}

Lee, Dong Ho ^{[7
]}

Lee, So Jung ^{[8
]}

Kulkarni, Suyash ^{[9
]}

Shree, Deepa ^{[10
]}

Tanaka, Masatoshi ^{[11
]}

机构：

[1] Okayama City Hosp, Dept Gastroenterol, Okayama 7008558, Japan

[2] Mitsui Mem Hosp, Tokyo 1018643, Japan

[3] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan

[4] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan

[5] Taipei Vet Gen Hosp, Taipei 11217, Taiwan

[6] Samsun Med Ctr, Seoul 06351, South Korea

[7] Seoul Natl Univ Hosp, Seoul 03080, South Korea

[8] Asan Med Ctr, Seoul 05505, South Korea

[9] Tata Mem Hosp, Mumbai 400012, Maharashtra, India

[10] Rela Inst & Med Ctr, Chennai 600044, Tamil Nadu, India

[11] Yokokura Hosp, Fukuoka 8390295, Japan

来源：

APPLIED SCIENCES-BASEL | 2020年 / 10卷 / 13期

关键词：

hepatocellular carcinoma; treatments; radiofrequency ablation; molecular target agents; hepatic arterial infusion chemotherapy; RADIOFREQUENCY ABLATION; CHEMOEMBOLIZATION; CHEMOTHERAPY; MANAGEMENT; SORAFENIB;

D O I：

10.3390/app10134607

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Many guidelines and standard therapies have been published for the treatment of hepatocellular carcinoma (HCC). Multiple options for the treatment of early to intermediate-stage HCC have resulted in several differences between the guidelines. In addition, more than a few non-standard therapies have been used in a real-world clinical setting. Radiofrequency ablation or chemotherapy, including hepatic arterial infusion chemotherapy and molecular target agents, are sometimes selected for the treatment of intermediate HCC, whereas in many guidelines, the recommended therapy for these patients is transcatheter arterial chemoembolization. The present status of these topics is reviewed and summarized.

引用

页数：7

共 50 条

[1] Treatment of intermediate-stage hepatocellular carcinoma
Fomer, Alejandro
Gilabert, Marine
Bruix, Jordi
Raoul, Jean-Luc
NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) : 525 - 535
[2] Treatment of Intermediate-Stage Hepatocellular Carcinoma
Finn, Richard S.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 501 - 503
[3] Treatment of intermediate-stage hepatocellular carcinoma
Alejandro Forner
Marine Gilabert
Jordi Bruix
Jean-Luc Raoul
Nature Reviews Clinical Oncology, 2014, 11 : 525 - 535
[4] Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical treatment
Suh, Suk-won
Lee, Kwang-Woong
Lee, Jeong-moo
Yoo, Tae
Choi, Youn-gRok
Yi, Nam-Joon
Suh, Kyung-Suk
HEPATOLOGY, 2013, 58 : 1238A - 1238A
[5] Early diagnosis and treatment of hepatocellular carcinoma
Llovet, JM
Bruix, J
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (06) : 991 - 1008
[6] PREDICTORS OF EARLY TREATMENT FOR HEPATOCELLULAR CARCINOMA
Cahill, M.
Burke, J.
Jafarimehr, E.
Farooq, S.
Weir, A.
Tombazzi, C.
Waters, B.
JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (02) : 463 - 463
[7] The intermediate hepatocellular carcinoma stage: Should treatment be expanded?
Piscaglia, Fabio
Bolondi, Luigi
DIGESTIVE AND LIVER DISEASE, 2010, 42 : S258 - S263
[8] New advances in the treatment of intermediate and advanced hepatocellular carcinoma
Jiang, Zhonghao
Yang, Fan
FRONTIERS IN ONCOLOGY, 2024, 14
[9] Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma
Vogel, Arndt
Saborowski, Anna
CANCER TREATMENT REVIEWS, 2020, 82
[10] The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
Lee, Ik Jae
Seong, Jinsil
GUT AND LIVER, 2012, 6 (02) : 139 - 148

← 1 2 3 4 5 →